Impact of Probiotics on Antibiotic-associated Diarrhea in Community-acquired Pneumonia
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age19-79
SponsorNational Health Insurance Service Ilsan Hospital
About this trial
The study goal is to determine whether oral administration of a probiotic mixture can reduce the incidence of antibiotic-associated diarrhea in patients with community-acquired pneumonia.
Eligibility criteria
Qualifiers
Adult patients aged 19 years or older admitted with a diagnosis of community-acquired pneumonia
Patients eligible for oral medication administration (able to take oral or enteral feeding)
Disqualifiers
Sepsis patients
Patients admitted to the intensive care unit (ICU) following endotracheal intubation
Elderly patients aged 80 years or older
Pregnant women
Trial design
Treatments tested in this trial
- Lacidofil
- Placebo
Treatment groups
100 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov